The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 503A vs. 503B: A Quick Guide to Compounding Pharmacy Designations & Regulations peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter